These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25261182)

  • 21. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
    Vulcano E; Gesell M; Esposito A; Ma Y; Memtsoudis SG; Gonzalez Della Valle A
    Int Orthop; 2012 Oct; 36(10):1995-2002. PubMed ID: 22684546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.
    Caprini JA; Arcelus JI; Motykie G; Kudrna JC; Mokhtee D; Reyna JJ
    J Vasc Surg; 1999 Nov; 30(5):813-20. PubMed ID: 10550178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty.
    Brotman DJ; Jaffer AK; Hurbanek JG; Morra N
    Thromb Haemost; 2004 Nov; 92(5):1012-7. PubMed ID: 15543328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DVT prophylaxis in total joint reconstruction.
    Sheth NP; Lieberman JR; Della Valle CJ
    Orthop Clin North Am; 2010 Apr; 41(2):273-80. PubMed ID: 20399366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.
    Friedman RJ
    J Am Acad Orthop Surg; 2007 Mar; 15(3):148-55. PubMed ID: 17341671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
    Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW;
    J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
    Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
    Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study.
    Prandoni P; Bruchi O; Sabbion P; Tanduo C; Scudeller A; Sardella C; Errigo G; Pietrobelli F; Maso G; Girolami A
    Arch Intern Med; 2002 Sep; 162(17):1966-71. PubMed ID: 12230419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty.
    Kodato K; Ishida K; Shibanuma N; Toda A; Takayama K; Oka S; Hayashi S; Hashimoto S; Kurosaka M; Kuroda R; Matsumoto T
    Eur J Orthop Surg Traumatol; 2018 Jan; 28(1):103-108. PubMed ID: 28766070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
    Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
    Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
    Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
    Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin responses in total joint and hip fracture patients.
    Messieh M; Huang Z; Johnson LJ; Jobin S
    J Arthroplasty; 1999 Sep; 14(6):724-9. PubMed ID: 10512445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of a clinical surveillance protocol with 3- and 6-week warfarin prophylaxis after total joint arthroplasty.
    Goldstein WM; Jimenez ML; Bailie DS; Wall R; Branson J
    Orthopedics; 2001 Jul; 24(7):651-4. PubMed ID: 11478551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
    Intermountain Joint Replacement Center Writing Committee
    J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.